CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a novel tumor vaccine using a modified viral vector to provide long-term surveillance and immunity against melanoma and lymphoma. The approach focuses on preventing cancer relapse by maintaining a low-level antigen release, promoting sustained immune responses in patients considered cancer-…
Melanoma and lymphoma are tumors that strike millions of people worldwide and require aggressive and expensive therapies.
Numerous therapies are already being used or in the pipeline, yet all of them focus on the rapid elimination of the active neoplastic process.
They do not provide options for long-term surveillance and deterrence of minimal residual disease, that is, of cancer relapse arising from the few tumor cells that survive the aggressive bout of therapy.
Therefore, even patients consid…
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
